RL
Insider
Richard L Md Lindstrom
DirectorRichard L Md Lindstrom (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Ocular Therapeutix, Inc. (OCUL). Across 1 priced purchase filing, the average 21-session return was +17.0% from execution and -4.1% from disclosure (delay-adjusted; derived). The largest single filing was $461K of OCUL (60,229 sh × $7.66, as filed), executed Feb 20.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+17.0%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-4.1%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$461K
shares × price, as filed
Last traded
Feb 20
Filed Feb 24
Median ADV $29.3M across their filed names
Open performance→Volume by month
Buys $461K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
OCULRecent filings
OCULPURCHASE
Ocular Therapeutix, Inc.
View filing →
$461K60,229 sh × $7.66
Exec Feb 20
Filed Feb 24 · 6:13 PM ET